Hooper, Lundy and Bookman Issues Commentary: FSMB Sharpens Regulator Focus on Corporate Influence and Oversight of Clinical Decision Making - What Physicians, MSOs, and Investors Need to Know
May 08, 2026
May 08, 2026
LOS ANGELES, California, May 8 -- Hooper, Lundy and Bookman, a law firm, issued the following commentary on May 7, 2026, by partner Eric M. Fish:
* * *
FSMB Sharpens Regulator Focus on Corporate Influence and Oversight of Clinical Decision Making: What Physicians, MSOs, and Investors Need to Know
On May 2, 2026, the Federation of State Medical Boards ("FSMB") approved the Report and Recommendations of the Workgroup on the Oversight of Clinical Dec . . .
* * *
FSMB Sharpens Regulator Focus on Corporate Influence and Oversight of Clinical Decision Making: What Physicians, MSOs, and Investors Need to Know
On May 2, 2026, the Federation of State Medical Boards ("FSMB") approved the Report and Recommendations of the Workgroup on the Oversight of Clinical Dec . . .